Dalfampridine

Back to search

Molecule Structure

Scientific Name

Dalfampridine

Description of the Drug

Dalfampridine is a potassium channel blocker used for the improvement of motor function in patients with multiple sclerosis (MS).

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB06637

Brand Name(s)

Ampyra, Ampyra Extended Release, Fampyra, Neurelan

Company Owner(s)

Hikma Pharmaceuticals Usa Inc, Mylan Pharmaceuticals Inc, Micro Labs Ltd, Actavis Laboratories Fl Inc, Acorda Therapeutics Inc, Alkem Laboratories Ltd, Sun Pharmaceutical Industries Ltd, Accord Healthcare Inc, Aurobindo Pharma Ltd

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Voltage-gated potassium channel PROTEIN FAMILY BLOCKER CHEMBL2362996

Unichem Links

SureChEMBL SCHEMBL53483
PharmGKB PA166123389
WDI AMINOPYR4
DrugBank DB06637
PubChem: Thomson Pharma 15194226
PubChem 1727
Mcule MCULE-6604546217
NMRShiftDB 10008866
LINCS LSM-45521
Nikkaji J1.568G J270.956B
BindingDB 10458
EPA CompTox Dashboard DTXSID0023870
DrugCentral 4163
Brenda 13387
ChemicalBook CB9853687
Guide to Pharmacology 2416
GSRS e3546bb7-07d8-4e56-9a9a-356fb04d14e1
rxnorm AMPYRA DALFAMPRIDINE
PubChem: Drugs of the Future 12014686
KEGG Ligand C13728
ChEBI 34385
ZINC ZINC000000599985